sun pharma q4 preview: strong growth in specialty biz likely to boost q4 performance | cnbc tv18
Published 1 year ago • 1K plays • Length 1:47
Download video MP4
Download video MP3
Similar videos
-
4:25
sun pharma q4 results | क्या strong growth in specialty biz likely to boost q4 performance | targets
-
2:17
sun pharma q4: revenue at ₹11,983 cr, misses est, net profit above est at ₹2,654.5 cr | cnbc tv18
-
10:07
sun pharma's cs muralidharan on q4 results, taro acquisition plans & fy24 outlook | halftime report
-
6:39
sun pharma reports a largely in-line set of q4 numbers; us sales come in at $430 m | cnbc tv18
-
1:33
q4fy24 results: clsa downgrades sun pharma to underperform; nomura neutral on gland pharma
-
3:14
libya oil production cuts will have a 'major impact' on markets: consulting firm
-
6:41
key stocks in focus: medi assist, gpt infraprojects, ceigall, zydus lifesciences, hcltech, coforge
-
7:04
the fed is 'misjudging' the current situation and no longer data dependent, says komal sri-kumar
-
7:21
pharma in q4fy24: health growth expected | what is systematix group's forecast for the sector?
-
5:25
sun pharma q4 profit rises 7%; beats estimates | #4qwithcnbctv18
-
2:14
pharma companies are likely to report 12-14% yoy sales growth in q4fy24 | cnbc tv18
-
7:16
watch cnbc tv18 live | sun pharma beats the street with ₹1,984 crore net profit in q4fy23
-
1:25
sun pharma q1fy25: net profit, ebitda, margin beat est; us formulation sales at $466 m | cnbc tv18
-
10:28
sun pharma q4 profit declines 53% to rs 635.9 crore due to one-time charge
-
4:16
us did well on account of specialty biz doing well, working on halol, mohali remediation: sun pharma
-
9:21
price pressure continues in the u.s. but is quite product-specific: sun pharma | cnbc tv18
-
0:32
d-street chatter | coforge, anant raj & sun pharma | n18s | cnbc tv18
-
23:34
sun pharma in focus | us fda to re-inspect halol unit | movers & shakers | cnbc tv18
-
1:23
sun pharma is a buying opportunity and you must keep it: sudarshan sukhani | cnbc tv18
-
1:11
expect to meet the guidance this year: sun pharma
-
5:14
specialty boost for sun pharma amid generics woes
-
1:53
sp tulsian shares his views on sun pharma stock | cnbctv18
Clip.africa.com - Privacy-policy